PubMed · 14755268
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Ronald T Hay. 2004. Modifying NEMO.. https://doi.org/10.1038/ncb0204-89
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Bacteria encounter acid stress under a variety of circumstances. Acid stress induces DNA damage and genomic instability, most directly via acid-catalyzed depurination reactions that generate apurinic (abasic, AP) sites on the deoxyribose phosphate backbone. DNA damage responses are important in bacterial resistance to acids. A recent report provided evidence that a DNA repair glycosylase, AlkX, which is capable of initiating the repair of interstrand DNA cross-links (ICLs), contributes to acid resistance by the pulmonary pathogen Acinetobacter baumannii (Kunkle et al. Proc. Nat. Acad. Sci. USA, 2024, 121, e2402422121). This suggested the possibility that AP-derived ICLs might contribute to the acid stress in bacteria. This idea is predicated on earlier work showing that AP sites can generate ICLs via reactions of the ring-opened AP aldehyde with the exocyclic amino groups of nucleobases on the opposing strand of duplex DNA (Price, N. E. J. Am. Chem. Soc. 2014, 136, 3483). However, it was not clear from previous work whether AP-derived ICLs could be generated under conditions of acid stress. The results reported here provide evidence for ICL formation under conditions of acid stress via a sequential process involving acid-catalyzed depurination followed by cross-linking of the resulting AP site with an adenine residue on the opposing strand of duplex DNA. This supports the possibility that AP-derived interstrand cross-links could contribute to the effects of acid stress in bacteria, and proteins involved in the repair of these lesions could be involved in resistance to acid stress.
Cells respond to DNA damage by activating DNA repair and DNA damage signaling pathways. While DNA repair proteins directly interact with DNA lesions, activation of DNA damage signaling pathways may be triggered by the effect the DNA lesions have on replication, transcription or chromatin topology. This review will focus on the potential mechanisms of the activation of DNA damage-induced signal transduction pathways.
The discoveries of nucleotide excision repair and transcription-coupled repair led by Phil Hanawalt and a few colleagues sparked a dramatic evolution in our understanding of DNA and molecular biology by revealing the intriguing systems of DNA repair essential to life. In fact, modifications of the cut-and-patch principles identified by Phil Hanawalt and colleagues underlie many of the common themes for the recognition and removal of damaged DNA bases outlined in this review. The emergence of these common themes and a unified understanding have been greatly aided from the direct visualizations of repair proteins and their interactions with damaged DNA by structural biology. These visualizations of DNA repair structures have complemented the increasing wealth of biochemical and genetic information on DNA base damage responses by revealing general themes for the recognition of damaged bases, such as sequence-independent DNA recognition motifs, minor groove reading heads for initial damage recognition, and nucleotide flipping from the major groove into active-site pockets for high specificity of base damage recognition and removal. We know that repair intermediates are as harmful as the initial damage itself, and that these intermediates are protected from one repair step to the next by the enzymes involved, such that pathway-specific handoffs must be efficiently coordinated. Here we focus on the structural biology of the repair enzymes and proteins that recognize specific base lesions and either initiate the base excision repair pathway or directly repair the damage in one step. This understanding of the molecular basis for DNA base integrity is fundamental to resolving key scientific, medical, and public health issues, including the evaluation of the risks from inherited repair protein mutations, environmental toxins, and medical procedures.